BIOLASE, INC

Delisted

CIK 811240fmd_1SZ31K0WY5F4B3M97181VGMGKGManufacturing · Dental Equipment & SuppliesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2024, 59 periods

Income Statement · Annual · Millions · USD
Line item	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023
Total revenues	48	48	52	47	46	38	23	39	48	49
Cost of revenue	29	33	32	32	29	24	17	23	33	32
Net interest income	–	0	0	0	(0)	–	–	–	–	–
Gross profit	18	16	20	15	17	14	6	17	16	17
Research and development	5	7	8	6	5	5	4	6	7	6
Selling, general and administrative	31	29	27	26	30	25	21	27	34	29
Total operating expenses	36	36	35	33	38	30	25	33	41	35
Operating income	(18)	(20)	(15)	(18)	(21)	(16)	(19)	(16)	(25)	(18)
Interest expense	0	–	–	–	–	–	–	–	–	–
Interest and investment income	–	–	–	–	–	–	–	–	–	–
Other non-operating income (expense)	(1)	(0)	(0)	1	(1)	2	2	0	(3)	(3)
Income before taxes	(19)	(20)	(15)	(17)	(21)	(18)	(17)	(16)	(29)	(21)
Income tax expense	0	0	0	(1)	0	(0)	0	0	0	0
Net income from continuing operations	(19)	(20)	(15)	(17)	(22)	(18)	(17)	(16)	(29)	(21)
Net income	(19)	(20)	(15)	(17)	(22)	(18)	(17)	(16)	(29)	(21)
Net income to common shareholders	(19)	(20)	(18)	(21)	(22)	(18)	(34)	(17)	(29)	(38)